BIOLIFE SOLUTIONS INC - 8-K Filing
BioLife Solutions reported Q1 2026 revenue of $27.5 million, up 25% YoY, with GAAP net income of $1.2 million and non-GAAP adjusted EBITDA of $6.2 million (22% of revenue). The company reiterated full-year guidance for revenue of $112.5–$115 million and mid-60% gross margins. (Items: 2.02 Results of Operations and Financial Condition, 9.01 Financial Statements and Exhibits)
Tickers: $BLFS